/platform-preview/verificationEditorial preview

Verification operations console

KYC review queue, OCR-extracted entity cards, beneficial-owner graph, and continuous sanctions screening for the focus entity. Tier-tracking continues from /methodology/verification.

Preview · live at Q3 2026

All data fictional · concept reference

app.afrosynergy.com/platform-preview/verification

Mock

Review queue

Entity cards

Sanctions log

Tier history

Open KYC reviews

Avg age 5.0d

OCR ≥ 90% confidence

73%

last 30d

Sanctions scans · 24h

14,820

0 hard flags

Adverse-media events

both clear

Document review queue

KYC-44012

Kumasi Premium Cocoa Co-op

Assigned · A. Mensah

T2→T3

Bylaws · Tax · Audited 2025 · 3 refs

OCR

96%

Age

KYC-44017

Stellenbosch Solar Pty

Assigned · L. Naidoo

T2→T3

CIPC · Tax · 2 refs · awaiting audit

OCR

88%

Age

KYC-44021

Mauritius Generics SE

Assigned · P. Ramgoolam

T3→T4

BAA · Reg.licence · DPA · UBO map · audit

OCR

99%

Age

11d

KYC-44024

Lobito Copper Concentrate

Assigned · J. Neto

T2→T3

Reg cert · awaiting financials + refs

OCR

72%

Age

KYC-44029

Cairo Pharma Distribution

Assigned · S. Tawfik

T1→T2

CR · KYC · bank conf · awaiting sector licence

OCR

91%

Age

OCR-extracted entity card · focus

KYC-44021 · MU

Mauritius Generics SE

Tier 3 verified

Entity type: Pharmaceutical manufacturer
Founded: 2018
Staff (declared): 142
Audited financials: 2024 · 2025

Beneficial ownership · upgrade request to Tier 4

P1Indian Ocean Pharma Hldgs54%
P2Africa Health Capital LLP28%
P3Founder family trust18%

Ultimate beneficial owners

P. RamgoolamT3
S. DeviT3
R. PillaiT3
D. Kumar Trust (estate)T2

Concept referenceThis is an editorial mock of how the live platform will surface this workflow. Exact UI may evolve through Q3 2026 launch. All counterparties, deal IDs, and financial figures are fictional; no production data is shown.